Prot# OOC-ACM-303: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Octreotide Capsules in Patients Who Previously Tolerated and Demonstrated Biochemical Control on Injectable Somatostatin Recep

Project: Research project

Project Details

StatusActive
Effective start/end date7/6/187/6/21

Funding

  • Pharm-Olam International Ltd. (Prot# OOC-ACM-303)
  • Chiasma, Inc. (Prot# OOC-ACM-303)